FRNRX
Price
$42.82
Change
+$0.30 (+0.71%)
Updated
Jul 13 closing price
Net Assets
487.82M
GRHAX
Price
$20.02
Change
+$0.12 (+0.60%)
Updated
Jul 13 closing price
Net Assets
968.51M
Interact to see
Advertisement

FRNRX vs GRHAX

FRNRX vs GRHAX Comparison Chart in %
View a ticker or compare two or three
VS
FRNRX vs. GRHAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRNRX is a Buy and GRHAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GRHAX has more cash in the bank: 969M vs. FRNRX (488M). GRHAX pays higher dividends than FRNRX: GRHAX (3.20) vs FRNRX (1.47). FRNRX was incepted earlier than GRHAX: FRNRX (31 years) vs GRHAX (10 years). GRHAX (1.52) is less costly to investors than FRNRX (1.01). GRHAX is a more actively managed with annual turnover of: 24.00 vs. FRNRX (19.72). FRNRX has a lower initial minimum investment than GRHAX: FRNRX (1000) vs GRHAX (3000). FRNRX annual gain was more profitable for investors over the last year : 36.70 vs. GRHAX (32.55). GRHAX return over 5 years is better than : 144.00 vs. FRNRX (121.43).
FRNRXGRHAXFRNRX / GRHAX
Total Expense Ratio1.001.2878%
Annual Report Gross Expense Ratio1.011.5266%
Fund Existence31 years10 years-
Gain YTD16.3972.842577%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets488M969M50%
Annual Yield % from dividends1.473.2046%
Returns for 1 year36.7032.55113%
Returns for 3 years56.9079.4772%
Returns for 5 years121.43144.0084%
Returns for 10 years82.97N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BGI0.55N/A
-0.04%
Birks Group
LAZ41.10-0.31
-0.75%
Lazard
EME764.90-16.88
-2.16%
EMCOR Group
CRBP9.04-0.64
-6.61%
Corbus Pharmaceuticals Holdings
DSGN13.85-1.33
-8.79%
Design Therapeutics